Harvett, in your haste to find fault by Noxopharm you appear to have missed the obvious. Some points:
1. As announced on 18 June, Eleanore Goodridge purchased 4,131,196 fully paid pro-rata Rights shares at a price of 13 cents each
2. As announced on 22 June, Eleanore Goodridge sold 4,131,196 shares in an Off Market sale (special crossing), at 13 cents each.
3. An amended announcement 45 minutes later confirmed that she had sold 4,131,196 shares at 13 cents each in an Off Market sale - but the 'special crossing' words did not appear.
Eleanore Gooodridge did not sell those shares as a "huge loss". She bought them of 13 cents each and sold them at the same price.
I suspect that this is simply a book-keeping exercise in which the shares have been moved into an associated account. It is something I have done in the past, is completely legal, and unexceptional.
A 'special crossing' suggest this was an internal transfer, but perhaps the wording needed to be changed for legal purposes.
NOX Price at posting:
19.5¢ Sentiment: Buy Disclosure: Held
